The Market Herald - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Alcidion Group (ALC) has signed a $2 million, six-year contract with U.K-based Dartford and Gravesham NHS Trust
  • The contract will roll out the Better OPENeP electronic prescribing and medication management solution
  • This is part of the Paperless at the Point of Care by 2020 nation-wide scheme
  • The information will be fully integrated and enhance clinical decision support
  • Alcidion is up 2.70 per cent today, with shares trading for 19 cents each

Alcidion Group (ALC) has signed a six-year contract with U.K-based Dartford and Gravesham NHS Trust that is valued at £1.02 million (A$1.9 million).

The contract will see Alcidion implement the OPENeP Electronic Prescribing and Medications Administration (ePMA) system produced by Better.

The agreement follows the company’s award back in July, as preferred provider by the Trust to deploy the OPENeP platform.

The agreement also extends Alcidion’s current relationship with Dartford and Gravesham, following the first implementation of the company’s full product suite in the U.K.

Dartford and Gravesham is an NHS Trust strategically planning to achieve full digital maturity by adopting integrated, best-of-breed technology solutions, and being Paperless at the Point of Care by 2020.

“Our approach to improving healthcare delivery is closely aligned with the goals of the Trust and we are excited to demonstrate the effectiveness of the consolidated solution,” Alcidion Managing Director Kate Quirke said.

The Patientrack solution, a bedside patient monitoring software, was implemented earlier this year. Planning is now underway to apply the Miya Precision and Smartpage solutions.

“We were excited by the range of technologies that Alcidion could provide us to achieve our objectives. Alcidion’s partnership with Better allows us to address electronic prescribing and medications management to further complete the picture,” Dartford and Gravesham Director of Digital Transformation Neil Perry said.

The overall aim is to ensure accurate and high-quality treatment for patients.

“By collaborating with Alcidion at Dartford and Gravesham NHS Trust, we aim to create an environment which maximises patient safety, improves collaboration among staff, and prevents unnecessary errors,” Better Business Unit Manager Roko Malkoč said.

The medication management information arising from OPENeP will be fully integrated and will enhance clinical decision support and extending the scope of the electronic patient record.

Alcidion is up 2.70 per cent today, with shares trading for 19 cents each at 10:16 am AEDT.

ALC by the numbers
More From The Market Herald

Little Green Pharma’s strong half-year performance signals robust Cannabis growth in Europe and Australia

Little Green Pharma (ASX:LGP) released its half-yearly financial report, showing revenue from ordinary cannabis sales is…

4DMedical inks MOU with Philips to expand XV Technology sales in North America

4DMedical (ASX:4DX) has signed a MOU with Philips to expand sales opportunities for its XV Technology…

Metagenics USA launches MetaSleep powered by The Calmer Co’s Kavaton extract

The Calmer Co International (ASX:CCO) has supplied its Kavaton extract to leading US practitioner supplements brand,…
Pharmaceutical dispensary

MedAdvisor invests $1.9m in UK pharmacy app for 7.4pc share

MedAdvisor (ASX:MDR) has announced it will invest nearly $2 million into UK-based pharmacy dispensary app Charac.